Form 8-K - Current report:
SEC Accession No. 0001193125-25-037650
Filing Date
2025-02-27
Accepted
2025-02-27 08:11:53
Documents
15
Period of Report
2025-02-27
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d916827d8k.htm   iXBRL 8-K 25637
2 EX-99.1 d916827dex991.htm EX-99.1 56763
6 GRAPHIC g916827dsp01.jpg GRAPHIC 13730
  Complete submission text file 0001193125-25-037650.txt   233677

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA iron-20250227.xsd EX-101.SCH 2865
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE iron-20250227_lab.xml EX-101.LAB 17994
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE iron-20250227_pre.xml EX-101.PRE 11271
17 EXTRACTED XBRL INSTANCE DOCUMENT d916827d8k_htm.xml XML 3635
Mailing Address 321 ARSENAL STREET, SUITE 101 WATERTOWN MA 02472
Business Address 321 ARSENAL STREET, SUITE 101 WATERTOWN MA 02472 (617) 674-9274
Disc Medicine, Inc. (Filer) CIK: 0001816736 (see all company filings)

EIN.: 851613057 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39438 | Film No.: 25673150
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)